AI in Immunotherapy

Feeds to Scour
SubscribedAll
Scoured 25 posts in 5.3 ms

PathTIGR: A pathway topology-informed graph representation learning framework for immunotherapy response prediction

 🧬neoatnigen
science.org·

Cancer Vaccine Produces 49% Melanoma Reduction in Patients Five Years Later

 🧬neoatnigen
goodnewsnetwork.org·

Blood test may predict immunotherapy response in head and neck cancer

 💉immunotherapy
medicalxpress.com·

How a sugar coating could make these cancer killers even more powerful

 💉immunotherapy  Content type: Academic
news.fiu.edu·
Less-relevant results

Cancer breakthroughs at ASCO

 🧬neoatnigen

HLA micropolymorphisms confine neoantigen conformational adaptability and guide T cell receptor selectivity

 🎯Neoantigen
pnas.org·

How China is getting ahead in biotech: a case study

 💉immunotherapy  Content type: News

How to build a cancer vaccine, and whether they will work this time

 🧬neoatnigen  Content type: News

A cholesterol drug may help cancer immunotherapy work better, but doctors need proof

 💉immunotherapy
earth.com·

CaliPPer: quantifying, predicting and improving AI model performance for binding prediction

 🎯Neoantigen  Content type: Academic
arxiv.org·

Richard Scolyer leaves a unique legacy of pioneering brain cancer research

 🧬neoatnigen
theconversation.com·

Ultrasound priming gated by solid tumor hallmarks to guide CAR-T therapy

 💉immunotherapy
science.org·

Immuneel Therapeutics Raises ₹100 Cr To Take Its Gene Therapy For Blood Cancer Global

 💉immunotherapy  Content type: Blog
askwiki.blogspot.com·

The blood cancer that became solvable

 💉immunotherapy

A man used ChatGPT to help make a cancer vaccine for his dog. Here’s how

 🧬neoatnigen  Content type: News
the-independent.com·

First report on the clinical efficacy of chemoimmunotherapy for ultra-rare urachal cancer

 🧬neoatnigen
medicalxpress.com·

Cured in China

 💉immunotherapy  Content type: News
worksinprogress.news·

Manufacturing requirements are killing cell and gene therapy

 💉immunotherapy  Content type: News
writingruxandrabio.com·

Cathie Wood's ARK Invest joins Cellares' $277M round to help bring cell therapies to more patients — TFN

 💉immunotherapy
techfundingnews.com·

Correcting a handful of misconceptions, inaccuracies and falsehoods in "The blood cancer that became solvable" by Ruxandra Teslo and Amol Punjabi

 💉immunotherapy  Content type: Blog
blog.miljko.org·

Keyboard Shortcuts

Navigation

Next / previous item
j/k
Open post
oorEnter
Preview post
v

Post Actions

Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Save / unsave
s

Recommendations

Add interest / feed
Enter
Not interested
x

Go to

Home
gh
Interests
gi
Feeds
gf
Likes
gl
History
gy
Changelog
gc
Settings
gs
Browse
gb
Search
/

General

Show this help
?
Submit feedback
!
Close modal / unfocus
Esc

Press ? anytime to show this help